Healthy Skepticism Library
Items published during the years 1970 to 1979
There are 379 items in the Healthy Skepticism Library that were published during the years 1970 to 1979.
Page 1 of 4 pages 1 2 3 > Last ›
HSL3024
Chapman S.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 29; 66:700
HSL3023
Ferris JD.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 17; 66:550
HSL2990
Feinstein AR, Horwitz RI.
Avoiding conflicts of interest in drug research.
N Engl J Med 1979 Nov 1; 301:(18):1009
HSL2993
Greenberg BG.
Avoiding conflicts of interest in drug research.
N Engl J Med 1979 Nov 1; 301:(18):1008
HSL3004
Relman AS.
Who reviews the ads?
N Engl J Med 1979 Nov 1; 301:(18):999
HSL3022
Tannock IF.
Responsibility in advertising: an oncologist's view
New England Journal of Medicine 1979 Nov 1; 300:1004
HSL2987
Chapman S.
Advertising and psychotropic drugs: the place of myth in ideological reproduction.
Soc Sci Med [Med Psychol Med Sociol] 1979 Nov; 13A:(6):751-64
HSL3021
Kleinman G.
The physician’s drug adoption process re: product risk
Medical Marketing & Media 1979 Nov; 14:46, 48-50
HSL16701
Wolfe S
The Conflict Between Individual Freedom and Social Control: Saccharin and Food Additives
Ann N.Y. Acad. Sci 1979 Nov; 329:42‑245
HSL16702
Wolfe S
The Dichotomy Between Theory and Practice in Risk/Benefit Analysis
Ann N.Y. Acad. Sci 1979 Nov; 329:274‑276
HSL8546
Leclerc Chevalier D
Ottawa report: Bureau of Drug Quality Assessment
Canadian Pharmaceutical Journal 1979 Oct; 112:293-294
HSL8550
Fink JL.
Marketing in a generic environment: pharmacist's view
Medical Marketing and Media 1979 Oct; 14:40, 42, 44, 46
HSL3017
Dukes MN.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Sep 29; 2:(8144):696
HSL2991
Fitzgerald FT.
Detail men in white coats.
N Engl J Med 1979 Sep 20; 301:(12):668
HSL3016
Burley DM.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Aug 18; 2:(8138):354
HSL3002
Petsonk EL.
Conflicts of interest in drug research.
N Engl J Med 1979 Aug 9; 301:(6):335
HSL8551
Barbieri J.
New prescription drug labeling requirement
US Pharmacist 1979 Aug; 4:19-21
HSL3015
Lunde PK, Herxheimer A.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Jul 28; 2:(8135):197
HSL3008
Solomon F, Mendelson WB.
Sleeping pills.
N Engl J Med 1979 Jul 26; 301:(4):214-5
HSL3014
Kelly NR.
Prescription drug advertising
Medical Journal of Australia 1979 Jul 14; 66:40
HSL3006
Schwartz H.
Junk mail.
N Engl J Med 1979 Jul 5; 301:(1):53
HSL3007
Snead OC.
Junk mail.
N Engl J Med 1979 Jul 5; 301:(1):53
HSL3010
Stock SL.
Junk mail.
N Engl J Med 1979 Jul 5; 301:(1):53
HSL8547
Najman JM, Siskind V, Bain C.
Prescription drug advertising: medical journal practices under different types of control.
Med J Aust 1979 May 19; 1:(10):420-4
HSL2988
Christensen DB, Wertheimer AI.
Sources of information and influence on new drug prescribing among physicians in an HMO.
Soc Sci Med 1979 May; 13A:(3):313-22
HSL2980
Binns TB, Smith A.
Medical representatives.
Br Med J 1979 Apr 28; 1:(6171):1134-5
HSL3005
Relman AS.
The sulindac story: what is medical news?
N Engl J Med 1979 Mar 29; 300:(13):733-4
HSL3011
Thompson EL.
Sexual bias in drug advertisements.
Soc Sci Med 1979 Mar; 13A:(2):187-91
HSL8541
Independents: holding their own
National Association of Retail Druggists Journal 1979 Mar; 101:23-24
HSL3012
Wasner C, Kotzin B.
Sulindac "public relations" deplored.
N Engl J Med 1979 Feb 15; 300:(7):373
HSL1878
Kaplan NM.
Sounding Boards.The support of continuing medical education by pharmaceutical companies
N Engl J Med 1979 Jan 25; 300:(4):194-6
HSL3009
Solomon SD, Grimmett BL, Maurer KH, Levin NW.
Complaint about promotion of new anti-arthritic drug.
N Engl J Med 1979 Jan 25; 300:(4):203
HSL2996
Lion JR, Regan BL, Taylor RJ, Kutzer DJ.
Psychiatrists' opinions of psychotropic drug advertisements.
Soc Sci Med [Med Psychol Med Sociol] 1979 Jan; 13A:(1):123-5
HSL2989
Editor .
Publicity about sulindac [Editor's reply]
New England Journal of Medicine 1979; 300:(13):735
HSL2992
Frisof KB, Parnicky K.
The burden of junk mail
New England Journal of Medicine 1979; 300:865-866
HSL2994
Hughes R, Brewin R.
The tranquilizing of America: pill popping and the American way of life
1979;
HSL2995
Kaplan NM.
The support of continuing medical education by pharmaceutical companies
New England Journal of Medicine 1979; 300:194-196
HSL2997
Lobo F.
Monopolistic structures and industrial analysis in Spain: the case of the pharmaceutical industry.
Int J Health Serv 1979; 9:(4):663-82
HSL2998
Mallace AH.
Publicity about sulindac [2nd of 4 letters]
New England Journal of Medicine 1979; 300:(13):734
HSL2999
Martin RW.
Diuretic equivalence of frusemide preparations
New Zealand Medical Journal 1979; 90:209
HSL3000
Miller DR.
Publicity about sulindac [3rd of 4 letters]
New England Journal of Medicine 1979; 300:(13):735
HSL3001
Miller JA, Waller R.
Health care advertising: consumer vs. physician attitudes
Journal of Advertising 1979; 8:(4):20-29
HSL3003
Pyeritz RE.
The burden of junk mail
New England Journal of Medicine 1979; 301:866
HSL9077
Medawar C.
Insult or Injury
London: Social Audit 1979
http://www.amazon.co.uk/Insult-Injury-Charles-Medawar/dp/0950339210/ref=sr_1_6/026-0515181-7375631?ie=UTF8&s=books&qid=1175254557&sr=1-6
HSL2958
Green B.
The politics of psychoactive drug use in old age.
Gerontologist 1978 Dec; 18:(6):525-30
HSL2964
Kunin CM.
Clinical investigators and the pharmaceutical industry.
Ann Intern Med 1978 Nov; 89:(5):
HSL8559
Kunin CM.
Problem of antibiotic usage. Definitions, causes, and proposed solutions
Ann Intern Med. 1978 Nov; 89:(5):802-5.
HSL2963
Kalb CC.
Psychological motivations in physician prescribing habits.
Med Mark Media 1978 Oct; 13:(10):43-5,
HSL8549
Kalb CL.
Psychological motivations in physician prescribing habits
Medical Marketing and Media 1978 Oct; 13:43-45, 49, 50, 52, 54, 55
HSL8553
What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 2
Pharmacy Times 1978 Oct; 44:45-49
HSL2314
Dajda R.
Drug advertising and prescribing.
J R Coll Gen Pract 1978 Sep; 28:(194):538-41
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=739456&query_hl=23
HSL2973
Talley CR.
Hospitals defend formulary decisions against industry attacks.
Am J Hosp Pharm 1978 Sep; 35:(9):1154-5
HSL8552
What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 1
Pharmacy Times 1978 Sep; 44:54-58
HSL16700
Wolfe S
Now, Let the Victim Beware
Mother Jones 1978 Sep14-18
HSL2972
Shearer SW, Gagnon JP, Eckel FM.
Community, hospital and clinical pharmacists and drug information centers as physician drug information sources.
Am J Hosp Pharm 1978 Aug; 35:(8):909-14
HSL2976
Walton H.
A case for medical journal advertising
Medical Marketing & Media 1978 Aug; 13:37-43
HSL8560
Gardner VR, Fulda TR.
Drug insurance and cost containment: an evaluation of where we're going.
Hosp Formul 1978 Jun; 13:(6):460-1,
HSL3013
Paine TF.
Advertising (quantified)
JAMA1979 May 25;241(21):2264 1979 May 25; 241:(21):2264
HSL8548
Braucher CL.
Pharmacy ethics-professional idealism and reality
American Journal of Pharmaceutical Education 1978 May; 42:141-143
HSL2975
Peretz SM.
Medical journal advertising as currently viewed by the pharmaceutical industry.
J R Soc Med 1978 Apr; 71:(4):282-4
HSL8561
Annual survey report-research and development activities ethical pharmaceutical industry, 1976 with forecast for 1977
Medical Marketing and Media 1978 Mar; 13:17-18, 20-24, 26-30
HSL2957
Medical journals and advertising
N Z Med J. 1978 Feb 22; 87:(606):139
HSL8555
Dolan M.
Target practice at FDA: talking back to the regulators
American Pharmacy 1978 Feb; 36-40
HSL2971
Roustan PT.
The pharmaceutical manufacturers representative.
Drug Inf J 1978 Jan-Mar; 12:(1):15-9
HSL8563
Garton WM.
Pharmaceutical industry in Canada: its environment and performance
Canadian Pharmaceutical Journal 1978 Jan; 111:6-7
HSL2959
Harrell GD, Lindsay CM.
Pharmaceutical marketing
1978; 69-90
HSL2960
Holmes JD.
Drug advertisements information
New Zealand Medical Journal 1978; 87:226
HSL2961
Holst H.
Unsolicited advertising
Canadian Medical Association Journal 1978; 118:24
HSL2962
Hornbrook MC.
Market structure and advertising in the US pharmaceutical industry
Medical Care 1978; 16:90-109
HSL2965
Lall S, Bibile S.
The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976.
Int J Health Serv 1978; 8:(2):299-328
HSL2966
Larson LN, Smith MC.
An analysis of the effects of “fair balance” in prescription drug advertising
Medical Marketing & Media 1978; 13:(6):26-27, 31
HSL2967
Martin RW.
Drug advertisements
New Zealand Medical Journal 1978; 87:295
HSL2968
Phillips JS.
Drug advertisements
New Zealand Medical Journal 1978; 87:102-103
HSL2969
Rheinstein PH, Hugstad PS.
The regulation of prescription drug advertising
1978; 407-416
HSL2970
Rice DI.
Misleading advertising of drug products
Canadian Family Physician 1978; 24:101-102
HSL2974
Yudkin JS.
Provision of medicines in a developing country
Lancet 1978; 1:810-812
HSL2977
Eastman M.
The day the detail man talked
American Pharmacy 1978; 18:(11):592
HSL2978
Ahmad S, Sheikh AI, Meeran MK.
Publicity about sulindac [1st of 4 letters]
New England Journal of Medicine 1978; 300:(13):734
HSL2979
Bell W.
Accredited pharmaceutical manufacturers representatives
Canadian Medical Association Journal 1978; 120:1327
HSL2986
Blakeslee A.
Publicity about sulindac [4th of 4 letters]
New England Journal of Medicine 1978; 300:(13):735
HSL8556
Presentation of price lists
Krankenhaus Apotheke 1978; 28:(2):15-16
HSL8558
Haines BA.
Worldwide regulations and legislation; their effects on pharmaceutical product development
Drug Development and Industrial Pharmacy 1978; 4:(1):1-30
HSL19891
Phillips PJ
Kill or Cure: Lotions, Potions, Characters and Quacks of Early Australia Richmond, Vic: Greenhouse Publishing 19780
http://www.blaqbooks.com.au/index.php?route=product/product&path=49&product_id=1599
HSL8562
Wheeler V.
MSD unveils first computer controlled drug plant
Drug Cosmet Ind 1977 Dec; 121:48-50
HSL2932
Holmes JD.
Prescribing information in drug advertisements.
N Z Med J 1977 Nov 23; 86:(600):467-9
HSL2921
Dixon RB.
The current status of guidelines for clinical research from the viewpoint of the pharmaceutical industry.
J Clin Pharmacol 1977 Nov-Dec; 17:(11-12):691-6
http://jcp.sagepub.com/cgi/reprint/17/11/691
HSL8565
Smith MC.
Drug product advertising and prescribing: a review of the evidence.
Am J Hosp Pharm 1977 Nov; 34:(11):1208-24
HSL2920
Da Sylva NP.
Drug information sources for the practicing physician.
Drug Inf J 1977 Oct-Dec; 11:(4):235-7
HSL2935
Marchand CR.
Physician attitudes toward sources of drug information.
Drug Inf J 1977 Oct-Dec; 11:(4):225-6
HSL2937
Meadows RJ.
Drug information: the pharmaceutical manufacturer's viewpoint and involvement.
Drug Inf J 1977 Oct-Dec; 11:(4):221-4
HSL2943
Stahl E.
The medical copywriter in the pharmaceutical industry: an uphill climb after a downhill slide.
Drug Inf J 1977 Oct-Dec; 11:(4):215-7
HSL2929
Holland AE.
Representatives and advertisements as sources of information.
Postgrad Med J 1977 Sep; 53:(623):559-61
HSL2933
Kenny EC.
Information centres in the pharmaceutical industry--the prime source of drug information.
Postgrad Med J 1977 Sep; 53:(623):562-5
HSL2955
Brown P.
Pharmaceutical promotion in Europe - regulations and restrictions
Medical Marketing & Media 1977 Sep; 12:(9):27, 30, 32, 34, 36, 38
HSL2956
Smith MC, Strecker P, Hair JF.
Sex appeals in prescription drug advertising
Medical Marketing & Media 1977 Sep; 12:(9):64, 66-70
HSL2936
Martin RW.
Drug costs.
N Z Med J 1977 Aug 24; 86:(594):202
HSL2938
Russell WL, Dahlin PA.
Industry's interest.
Drug Intell Clin Pharm 1977 Aug; 11:(8):493-4
HSL2954
Mergener M.
Detailmen: Their pharmaceutical knowledge and continuing education
Medical Marketing & Media 1977 Aug; 12:(8):26, 28-31
HSL2930
Holmes JD.
Drug costs.
N Z Med J 1977 Jul 27; 86:(592):108-9
HSL2953
Kunin CM.
Blunder drug for pneumonia.
N Engl J Med 1977 Jul 14; 297:(2):113-4
Page 1 of 4 pages 1 2 3 > Last ›
